Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Merck Sharpe & Dohme Formulation Plant

Order year

Late 2001

Project type

Formulation facility

Location

Tuas, Singapore

Estimated investment

$100 million

Completion

October 2003

Output chemicals

Combination cholesterol therapy. Zocor and Ezetrol (Zetia)

Sponsor

MSD Technology Singapore Pte Ltd

Lead engineer / designer

Foster Wheeler

Validation

Foster Wheeler

Contractor

Hycon

Financing

Merck Sharpe & Dohme
Expand

Free download worth over $5000
Download our 2019 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes for 2019, identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TM
Close
Close
Close

Go Top